Today: 26 June 2026
AI stock price: C3.ai slips at the close as Fed decision and Big Tech earnings loom
27 January 2026
1 min read

AI stock price: C3.ai slips at the close as Fed decision and Big Tech earnings loom

New York, January 27, 2026, 17:00 EST — After-hours

  • C3.ai ended Tuesday’s session down and showed little movement after hours.
  • Wall Street braces for the Fed’s Jan. 28 decision alongside a surge of megacap tech earnings.
  • AI-linked stocks are reacting to spending and demand signals from Big Tech earnings.

C3.ai (NYSE:AI) shares dropped 2.4% to close Tuesday at $12.62, before edging slightly higher to $12.65 in after-hours trading, which occurs outside the standard 9:30 a.m. to 4 p.m. session.

The decline happened as the S&P 500 notched a record closing high, with investors gearing up for a packed week of earnings reports and a Federal Reserve decision. “The market seems to be hanging in there waiting for a big week of earnings,” said Phil Blancato, chief market strategist at Osaic Wealth, in a Reuters interview. Reuters

The Federal Open Market Committee of the Federal Reserve will convene on Jan. 27-28, with its policy announcement scheduled for Wednesday.

Investors are zeroing in on Big Tech earnings, eager for tangible returns on AI investments. Microsoft and Meta announce results Wednesday, with Alphabet and Amazon due next week, Reuters reported. Microsoft, Meta, and Amazon are all set to boost AI spending by roughly 30%, pushing total outlays beyond $500 billion this year.

C3.ai climbed 1.9% Monday to close at $12.93, though it remains roughly 64% off its 52-week peak of $35.98, MarketWatch reports. Trading volume hit about 4 million shares, falling short of the 50-day average of 5.9 million.

On Dec. 3, C3.ai released its latest quarterly report, showing total revenue of $75.1 million and subscription revenue hitting $70.2 million. The company recorded a GAAP loss of 75 cents per share. It wrapped the quarter with $675 million in cash, cash equivalents, and marketable securities. CEO Stephen Ehikian highlighted the federal market as “a large growth vector” for the firm. C3 AI

High-beta AI stocks have shown they can swing quickly when rates or guidance change, and C3.ai has demonstrated that pattern throughout much of the past year. Chris Zaccarelli, chief investment officer at Northlight Asset Management, told Reuters on Monday that “guidance will be especially important” for the AI trade and described investors as “cautiously optimistic.” Reuters

Wednesday brings the Fed statement, then earnings from Meta, Microsoft, and Tesla, all under close watch for shifts in AI spending or demand signals. C3.ai is set to report earnings March 4, according to TradingView data.

C3.ai faces a straightforward test: can enterprise AI spending translate into rising subscription revenue and larger contracts? The key dates are set — Jan. 28 and March 4 — and the stock is expected to move accordingly.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Zacks Starts Coverage on Versus Systems Highlighting Gamification Strategy
    June 26, 2026, 1:18 PM EDT. Zacks Investment Research has initiated coverage on Versus Systems (NASDAQ: VS), spotlighting the company's progress in gamification and audience engagement. Based in Austin, Texas, Versus Systems is advancing its platform that integrates gaming elements into non-gaming contexts to boost user interaction. Zacks sees potential growth driven by expanding adoption of gamification in marketing and entertainment sectors. This move reflects increasing investor interest in companies leveraging technology to enhance consumer engagement. Versus Systems aims to capitalize on these trends as it broadens its market reach and product offerings.

Latest News

Moderna (NASDAQ:MRNA) gains $3.3 billion after CAR-T update

Moderna (NASDAQ:MRNA) gains $3.3 billion after CAR-T update

26 June 2026
Moderna soared 13.9% to $68.06 after unveiling mRNA-6007, an in vivo CAR-T candidate for autoimmune disease, at its Science Day, adding $3.3 billion in equity value—more than its 2026 R&D forecast—despite no near-term sales boost, with analysts split on future prospects and cash burn risks.
Lumen Technologies (LUMN) stock jumps on ISO 42001 AI certification as earnings loom
Previous Story

Lumen Technologies (LUMN) stock jumps on ISO 42001 AI certification as earnings loom

National Grid share price holds near fresh 52-week high as €650m bond sale puts funding back in focus
Next Story

National Grid share price holds near fresh 52-week high as €650m bond sale puts funding back in focus

Go toTop